References
- Baselga J, Swain SM. CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancer. Clin Breast Cancer. 2010;10:489–12. doi:https://doi.org/10.3816/CBC.2010.n.065.
- Havelund S, Ribel U, Hubalek F, Hoeg-Jensen T, Wahlund PO, Jonassen I. Investigation of the physico-chemical properties that enable co-formulation of basal insulin degludec with fast-acting insulin aspart. Pharm Res. 2015;32:2250–58. doi:https://doi.org/10.1007/s11095-014-1614-x.
- Schmidt C. The benefits of immunotherapy combinations. Nature. 2007;552:S67–S69. doi:https://doi.org/10.1038/d41586-017-08702-7.
- Kaplon H, Reichert JM. Antibodies to watch in 2018. mAbs. 2018;10:183–203. doi:https://doi.org/10.1080/19420862.2018.1415671.
- Lagasse HA, Alexaki A, Simhadri VL, Katagiri NH, Jankowski W, Sauna ZE, Kimchi-Sarfaty C. Recent advances in (therapeutic protein) drug development. F1000Res. 2017;6:113. doi:https://doi.org/10.12688/f1000research.9970.1.
- Koefoed K, Steinaa L, Soderberg JN, Kjaer I, Jacobsen HJ, Meijer PJ, Haurum JS, Jensen A, Kragh M, Andersen PS, et al. Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor. mAbs. 2011;3:584–95. doi:https://doi.org/10.4161/mabs.3.6.17955.
- Rasmussen SK, Naested H, Muller C, Tolstrup AB, Frandsen TP. Recombinant antibody mixtures: production strategies and cost considerations. Arch Biochem Biophys. 2012;526:139–45. doi:https://doi.org/10.1016/j.abb.2012.07.001.
- US Food and Drug Administration. Guidance for industry: codevelopment of two or more new investigational drugs for use in combination. Center for drug evaluation and research. Rockville (MD): US Food and Drug Administration; 2013.
- Cho IH, Lee N, Song D, Jung SY, Bou-Assaf G, Sosic Z, Zhang W, Lyubarskaya Y. Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept. mAbs. 2016;8:1136–55. doi:https://doi.org/10.1080/19420862.2016.1193659.
- Glover ZW, Gennaro L, Yadav S, Demeule B, Wong PY, Sreedhara A. Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration. J Pharm Sci. 2013;102:794–812. doi:https://doi.org/10.1002/jps.23403.
- Ott PA, Hodi FS, Kaufman HL, Wigginton JM, Wolchok JD. Combination immunotherapy: a road map. J Immunother Cancer. 2017;5:16. doi:https://doi.org/10.1186/s40425-017-0218-5.
- Alt N, Zhang TY, Motchnik P, Taticek R, Quarmby V, Schlothauer T, Beck H, Emrich T, Harris RJ. Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals. 2016;44:291–305. doi:https://doi.org/10.1016/j.biologicals.2016.06.005.
- Haverick M, Mengisen S, Shameem M, Ambrogelly A. Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications. mAbs. 2014;6:852–58. doi:https://doi.org/10.4161/mabs.28693.
- Cao M, De Mel N, Shannon A, Prophet M, Wang C, Xu W, Niu B, Kim J, Albarghouthi M, Liu D, et al. Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy. mAbs. 2019;11:489–99. doi:https://doi.org/10.1080/19420862.2019.1578137.
- Schuck P. On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal Biochem. 2003;320:104–24. doi:https://doi.org/10.1016/s0003-2697(03)00289-6.
- Wei JY, Bou-Assaf GM, Houde D, Weiskopf A. Technical decision-making with higher-order structure data: detecting reversible concentration-dependent self-association in a monoclonal antibody and a preliminary investigation to eliminate it. J Pharm Sci. 2015;104:3984–89. doi:https://doi.org/10.1002/jps.24616.
- Esfandiary R, Hayes DB, Parupudi A, Casas-Finet J, Bai S, Samra HS, Shah AU, Sathish HA. A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies. J Pharm Sci. 2013;102:3089–99. doi:https://doi.org/10.1002/jps.23654.
- Velázquez-Campoy AOH, Nezami A, Muzammil S, Freire E. Isothermal titration calorimetry. Current Protoc Cell Biol. 2004;23:17.18.11–17.18.24. doi:https://doi.org/10.1002/0471143030.cb1708s23.